INSIGHTS ON CLINICAL TRIAL DESIGN
-
Guiding GLP-1 Participants Through The Challenge Of Retention
Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.
-
Endpoint Clinical RTSM: Getting The Job Done
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
Beyond Help Desk: RTSM Support Ready For Change
This clip explores what sponsors should expect from an RTSM support model built for long‑term study needs, emphasizing capacity, flexibility, and readiness to adapt as trials evolve.
-
Critical Inputs For Configuring An RTSM
Uncover why clearly defined visit schedules and dispensing events are essential in RTSM design — and how resolving protocol ambiguity early prevents downstream complexity across systems and sites.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
Innovative Approaches In Oncology Clinical Trials2/6/2025
By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays3/30/2026
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
DCT Solutions That Successfully Deliver Results10/28/2025
Catch MRN COO, Todd McGrath, speaking on the impact DCT/hybrid trial design can have on overall trial success, noting that there is no "one-size-fits-all" — it takes a tailored approach to achieve maximum results.
-
Mastering Scope 3 Emissions In Clinical Trials10/23/2024
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.
-
Plug in your trial details and see the impact of live data capture on queries, timelines, and source data quality.
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.